Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glix 13, a new drug acting on glutamatergic pathways in children and animal models of autism spectrum disorders.

BioMed research international - 1 Jan 2014

Santini Annamaria Chiara, Pierantoni Giovanna Maria, Gerlini Raffaele, Iorio Rosamaria, Olabinjo Yinka, Giovane Alfonso, Di Domenico Marina, Sogos Carla

Abstract excerpt

Recently standardized diagnostic instruments have been developed in diagnostic and therapeutic procedures for Autism Spectrumv Disorders (ASD). According to the DSM-5 criteria, individuals with ASD must show symptoms from early childhood. These symptoms are communication deficits and restricted, repetitive patterns of behaviour. It was recently described by Bioinformatic analysis that 99 modified genes were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Child Development Disorders, Pervasive

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Models, Animal

Share to Genetic Variation

Share to Glutamates

Share to Oligopeptides

Share to Receptors, N-Methyl-D-Aspartate

Source

Open in PubMed Open full text

Identifiers

PMID: 24605324
DOI: 10.1155/2014/234295
PMCID: PMC3925524

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glix 13, a new drug acting on glutamatergic pathways in children and animal models of autism spectrum disorders.PMID 24605324Read ↗

Unraveling the Role of Neuroligin3 in Autism Spectrum Disorders: Pathophysiological Insights and Targeted Therapies.Semantic proximity Read ↗

Glycine receptor mouse mutants: model systems for human hyperekplexia.Semantic proximity Read ↗

Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autismSemantic proximity Read ↗

Glyoxalase 1 Inhibitor Alleviates Autism-like Phenotype in a Prenatal Valproic Acid-Induced Mouse Model.Semantic proximity Read ↗

Sensitivity to isoflurane anesthesia increases in autism spectrum disorder Shank3+/∆c mutant mouse model.Semantic proximity Read ↗

Neuroligin‐3‐deficient mice: model of a monogenic heritable form of autism with an olfactory deficitSemantic proximity Read ↗

Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?Semantic proximity Read ↗

Glycine-modulating Slc6a20a-ASO restores NMDA receptor function in SHANK2 and SHANK3-mutant mice and cortical organoids.Semantic proximity Read ↗

Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders.Semantic proximity Read ↗

Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity.Semantic proximity Read ↗

Drug-responsive autism phenotypes in the 16p11.2 deletion mouse model: a central role for gene-environment interactions.Semantic proximity Read ↗

[Autism, chromosome 15 and the GAbaergic dysfunction hypothesis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.